Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression.
Courtwright AM, Kamoun M, Diamond JM, Kearns J, Ahya VN, Christie JD, Clausen E, Hadjiliadis D, Patel N, Salgado JC, Cevasco M, Cantu EE, Crespo MM, Bermudez CA.
Courtwright AM, et al. Among authors: kearns j.
Clin Transplant. 2021 Nov;35(11):e14447. doi: 10.1111/ctr.14447. Epub 2021 Sep 12.
Clin Transplant. 2021.
PMID: 34365656